ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NCI, MABCO Publish Clinical Trials Web Site

September 6, 1996

Surgical Oncologists Honor HHS Secretary

March 22, 2002

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

Roswell Park Wins $2.8 Million Grant

July 31, 2009

Poll Finds Strong Support For Research; Yarbro Leads International Cancer Nurses.

October 6, 2000

NIH wins A-76 competition for extramural support services.

September 26, 2003